Unlike Th1, Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation-induced cell death

Journal of Immunology

Volumn 183, Issue 11, 2009, Pages 7547-7556

  Shi, Guangpu ^a   Ramaswamy, Madhu ^b   Vistica, Barbara P ^a   Cox, Catherine A ^a   Tan, Cuiyan ^a   Wawrousek, Eric F ^a   Siegel, Richard M ^b   Gery, Igal ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; FAS ANTIGEN; INTERLEUKIN 17; LYSOZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CHRONIC INFLAMMATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; EYE INFLAMMATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; ADOPTIVE TRANSFER; ANIMAL; AUTOIMMUNE DISEASE; BIOSYNTHESIS; CELL DIVISION; EYE; FLOW CYTOMETRY; IMMUNOLOGY; INFLAMMATION; METABOLISM; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; EYE; FAS LIGAND PROTEIN; FLOW CYTOMETRY; INFLAMMATION; INTERLEUKIN-17; MICE; MICE, TRANSGENIC; MURAMIDASE; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

EID: 73349127028     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900519     Document Type: Article

References (65)

1. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279.
2. Higgins, S. C., A. G. Jarnicki, E. C. Lavelle, and K. H. Mills. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177: 7980-7989.
3. Kullberg, M. C., D. Jankovic, C. G. Feng, S. Hue, P. L. Gorelick, B. S. McKenzie, D. J. Cua, F. Powrie, A. W. Cheever, K. J. Maloy, and A. Sher. 2006. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203: 2485-2494.
4. Aujla, S. J., Y. R. Chan, M. Zheng, M. Fei, D. J. Askew, D. A. Pociask, T. A. Reinhart, F. McAllister, J. Edeal, K. Gaus, et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14: 275-281.
5. H2 hypothesis of T-cell mediated tissue damage. Nat. Med. 13: 139-145.
6. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
7. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8: 337-348.
8. McGeachy, M. J., and D. J. Cua. 2008. Th17 cell differentiation: the long and winding road. Immunity 28: 445-453. (Pubitemid 351467042)
9. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27: 485-517.
10. Tesmer, L. A., S. K. Lundy, S. Sarkar, and D. A. Fox. 2008. Th17 cells in human disease. Immunol. Rev. 223: 87-113.
11. Pene, J., S. Chevalier, L. Preisser, E. Venereau, M. H. Guilleux, S. Ghannam, J. P. Moles, Y. Danger, E. Ravon, S. Lesaux, et al. 2008. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol. 180: 7423-7430.
12. Kotake, S., N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, et al. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103: 1345-1352.
13. Honorati, M. C., R. Meliconi, L. Pulsatelli, S. Cane, L. Frizziero, and A. Facchini. 2001. High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology 40: 522-527. (Pubitemid 32514717)
14. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Fili, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861.
15. Schmechel, S., A. Konrad, J. Diegelmann, J. Glas, M. Wetzke, E. Paschos, P. Lohse, B. Goke, and S. Brand. 2008. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Inflamm. Bowel Dis. 14: 204-212.
16. Matusevicius, D., P. Kivisakk, B. He, N. Kostulas, V. Ozenci, S. Fredrikson, and H. Link. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5: 101-104.
17. Montes, M., X. Zhang, L. Berthelot, D. A. Laplaud, S. Brouard, J. Jin, S. Rogan, D. Armao, V. Jewells, J. P. Soulillou, and S. Markovic-Plese. 2009. Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin. Immunol. 130: 133-144.
18. Zaba, L. C., I. Cardinale, P. Gilleaudeau, M. Sullivan-Whalen, M. Suarez-Farinas, J. Fuentes-Duculan, I. Novitskaya, A. Khatcherian, M. J. Bluth, M. A. Lowes, and J. G. Krueger. 2007. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204: 3183-3194.
19. + T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J. Allergy Clin. Immunol. 119: 1218-1224.
20. Amadi-Obi, A., C. R. Yu, X. Liu, R. M. Mahdi, G. L. Clarke, R. B. Nussenblatt, I. Gery, Y. S. Lee, and C. E. Egwuagu. 2007. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13: 711-718.
21. Cardoso, C. R., G. P. Garlet, G. E. Crippa, A. L. Rosa, W. M. Junior, M. A. Rossi, and J. S. Silva. 2009. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol. Immunol. 24: 1-6.
22. Elson, C. O., Y. Cong, C. T. Weaver, T. R. Schoeb, T. K. McClanahan, R. B. Fick, and R. A. Kastelein. 2007. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132: 2359-2370.
23. Kroenke, M. A., T. J. Carlson, A. V. Andjelkovic, and B. M. Segal. 2008. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205: 1535-1541.
24. O'Connor, R. A., C. T. Prendergast, C. A. Sabatos, C. W. Lau, M. D. Leech, D. C. Wraith, and S. M. Anderton. 2008. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 181: 3750-3754.
25. Luger, D., P. B. Silver, J. Tang, D. Cua, Z. Chen, Y. Iwakura, E. P. Bowman, N. M. Sgambellone, C. C. Chan, and R. R. Caspi. 2008. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 205: 799-810.
26. Cox, C. A., G. Shi, H. Yin, B. P. Vistica, E. F. Wawrousek, C. C. Chan, and I. Gery. 2008. Both Th1 and Th17 are immunopathogenic but differ in other key biological activities. J. Immunol. 180: 7414-7422.
27. Kebir, H., K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13: 1173-1175.
28. Yoshimura, T., K. H. Sonoda, Y. Miyazaki, Y. Iwakura, T. Ishibashi, A. Yoshimura, and H. Yoshida. 2008. Differential roles for IFN-γ and IL-17 in experimental autoimmune uveoretinitis. Int. Immunol. 20: 209-214.
29. Hoyer, K. K., W. F. Kuswanto, E. Gallo, and A. K. Abbas. 2009. Distinct roles of helper T-cell subsets in a systemic autoimmune disease. Blood 113: 389-395.
30. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188.
31. Lafaille, J. J., F. V. Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186: 307-312.
32. Lai, J. C., A. Fukushima, E. F. Wawrousek, M. C. Lobanoff, P. Charukamnoetkanok, S. J. Smith-Gill, B. P. Vistica, R. S. Lee, C. E. Egwuagu, S. M. Whitcup, and I. Gery. 1998. Immunotolerance against a foreign antigen transgenically expressed in the lens. Invest. Ophthalmol. Visual Sci. 39: 2049-2057.
33. Fujimoto, C., C. R. Yu, G. Shi, B. P. Vistica, E. F. Wawrousek, D. M. Klinman, C. C. Chan, C. E. Egwuagu, and I. Gery. 2006. Pertussis toxin is superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and their cytokine production. J. Immunol. 177: 6896-6903. (Pubitemid 44715055)
34. Flugel, A., T. Berkowicz, T. Ritter, M. Labeur, D. E. Jenne, Z. Li, J. W. Ellwart, M. Willem, H. Lassmann, and H. Wekerle. 2001. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14: 547-560. (Pubitemid 32520866)
35. Chen, J., B. P. Vistica, H. Takase, D. I. Ham, R. N. Fariss, E. F. Wawrousek, C. C. Chan, J. A. DeMartino, J. M. Farber, and I. Gery. 2004. A unique pattern of up- and down-regulation of chemokine receptor CXCR3 on inflammation-inducing Th1 cells. Eur. J. Immunol. 34: 2885-2894.
36. Kim, S. J., M. Zhang, B. P. Vistica, C. C. Chan, D. F. Shen, E. F. Wawrousek, and I. Gery. 2002. Induction of ocular inflammation by T-helper lymphocytes type 2. Invest. Ophthalmol. Visual Sci. 43: 758-765.
37. Steinman, L. 1996. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc. Natl. Acad. Sci. USA 93: 2253-2256.
38. Caspi, R. R., C. C. Chan, Y. Fujino, F. Najafian, S. Grover, C. T. Hansen, and R. L. Wilder. 1993. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis. J. Neuroimmunol. 47: 177-188.
39. Chen, J., C. Fujimoto, B. P. Vistica, J. He, E. F. Wawrousek, B. Kelsall, and I. Gery. 2006. Active participation of antigen-nonspecific lymphoid cells in immune- mediated inflammation. J. Immunol. 177: 3362-3368. (Pubitemid 44277856)
40. + T cells. J. Exp. Med. 179: 1539-1549.
41. Siegel, R. M., F. K. Chan, H. J. Chun, and M. J. Lenardo. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1: 469-474.
42. Dalton, J. E., G. Howell, J. Pearson, P. Scott, and S. R. Carding. 2004. Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by γδ T cells. J. Immunol. 173: 3660-3667.
43. Yang, J., S. F. Gallagher, K. Haines, P. K. Epling-Burnette, F. Bai, W. R. Gower, Jr., S. Mastorides, J. G. Norman, and M. M. Murr. 2004. Kupffer cell-derived Fas ligand plays a role in liver injury and hepatocyte death. J. Gastrointest. Surg. 8: 166-174.
44. Bonfoco, E., P. M. Stuart, T. Brunner, T. Lin, T. S. Griffith, Y. Gao, H. Nakajima, P. A. Henkart, T. A. Ferguson, and D. R. Green. 1998. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 9: 711-720.
45. Ferguson, T. A., and T. S. Griffith. 2006. A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol. Rev. 213: 228-238.
46. Takase, H., C. R. Yu, X. Liu, C. Fujimoto, I. Gery, and C. E. Egwuagu. 2005. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins. J. Neuroimmunol. 168: 118-127.
47. Laan, M., Z. H. Cui, H. Hoshino, J. Lotvall, M. Sjostrand, D. C. Gruenert, B. E. Skoogh, and A. Linden. 1999. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162: 2347-2352.
48. Witowski, J., K. Pawlaczyk, A. Breborowicz, A. Scheuren, M. Kuzlan-Pawlaczyk, J. Wisniewska, A. Polubinska, H. Friess, G. M. Gahl, U. Frei, and A. Jorres. 2000. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GROα chemokine from mesothelial cells. J. Immunol. 165: 5814-5821.
49. McGeachy, M. J., K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, T. McClanahan, and D. J. Cua. 2007. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain Th-17 cell-mediated pathology. Nat. Immunol. 8: 1390-1397.
50. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691.
51. Chung, Y., S. H. Chang, G. J. Martinez, X. O. Yang, R. Nurieva, H. S. Kang, L. Ma, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
52. Staschke, K. A., S. Dong, J. Saha, J. Zhao, N. A. Brooks, D. L. Hepburn, J. Xia, M. F. Gulen, Z. Kang, C. Z. Altuntas, et al. 2009. IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease. J. Immunol. 183: 568-577.
53. + regulatory T cells in NOD mice that can prevent diabetes development. PLoS One 3: e3739.
54. + regulatory T cell promotion. J. Immunol. 183: 2932-2945.
55. Ilarregui, J. M., D. O. Croci, G. A. Bianco, M. A. Toscano, M. Salatino, M. E. Vermeulen, J. R. Geffner, and G. A. Rabinovich. 2009. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 10: 981-991.
56. Lee, J. W., M. Epardaud, J. Sun, J. E. Becker, A. C. Cheng, A. R. Yonekura, J. K. Heath, and S. J. Turley. 2007. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat. Immunol. 8: 181-190.
57. Van Parijs, L., D. A. Peterson, and A. K. Abbas. 1998. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8: 265-274. (Pubitemid 28123753)
58. Wahlsten, J. L., H. L. Gitchell, C. C. Chan, B. Wiggert, and R. R. Caspi. 2000. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis. J. Immunol. 165: 5480-5486.
59. Sueda, J., N. Hikita, M. Mochizuki, A. Jimi, and M. Kojiro. 2000. Kinetics of apoptotic cells in experimental autoimmune uveoretinitis. Invest. Ophthalmol. Visual Sci. 41: 799-804.
60. Sabelko-Downes, K. A., A. H. Cross, and J. H. Russell. 1999. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 189: 1195-1205.
61. Suvannavejh, G. C., M. C. Dal Canto, L. A. Matis, and S. D. Miller. 2000. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 105: 223-231.
62. Stranges, P. B., J. Watson, C. J. Cooper, C. M. Choisy-Rossi, A. C. Stonebraker, R. A. Beighton, H. Hartig, J. P. Sundberg, S. Servick, G. Kaufmann, et al. 2007. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26: 629-641.
63. Zhang, Y., G. Xu, L. Zhang, A. I. Roberts, and Y. Shi. 2008. Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-γ. J. Immunol. 181: 190-196.
64. Shi, G., C. A. Cox, B. P. Vistica, C. Tan, E. F. Wawrousek, and I. Gery. 2008. Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells. J. Immunol. 181: 7205-7213.
65. Stritesky, G. L., N. Yeh, and M. H. Kaplan. 2008. IL-23 promotes maintenance but not commitment to the Th17 lineage. J. Immunol. 181: 5948-5955.